196 related articles for article (PubMed ID: 35996062)
41. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
[TBL] [Abstract][Full Text] [Related]
42. Calorie restriction outperforms bariatric surgery in a murine model of obesity and triple-negative breast cancer.
Camp KK; Coleman MF; McFarlane TL; Doerstling SS; Khatib SA; Rezeli ET; Lewis AG; Pfeil AJ; Smith LA; Bowers LW; Fouladi F; Gong W; Glenny EM; Parker JS; Milne GL; Carroll IM; Fodor AA; Seeley RJ; Hursting SD
JCI Insight; 2023 Sep; 8(19):. PubMed ID: 37698918
[TBL] [Abstract][Full Text] [Related]
43. Daily caloric restriction limits tumor growth more effectively than caloric cycling regardless of dietary composition.
Pomatto-Watson LCD; Bodogai M; Bosompra O; Kato J; Wong S; Carpenter M; Duregon E; Chowdhury D; Krishna P; Ng S; Ragonnaud E; Salgado R; Gonzalez Ericsson P; Diaz-Ruiz A; Bernier M; Price NL; Biragyn A; Longo VD; de Cabo R
Nat Commun; 2021 Oct; 12(1):6201. PubMed ID: 34707136
[TBL] [Abstract][Full Text] [Related]
44. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
[TBL] [Abstract][Full Text] [Related]
45. Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis.
Zhu H; Klement JD; Lu C; Redd PS; Yang D; Smith AD; Poschel DB; Zou J; Liu D; Wang PG; Ostrov D; Coant N; Hannun YA; Colby AH; Grinstaff MW; Liu K
J Immunol; 2021 Mar; 206(6):1395-1404. PubMed ID: 33547170
[TBL] [Abstract][Full Text] [Related]
46. MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC.
Franklin DA; Sharick JT; Ericsson-Gonzalez PI; Sanchez V; Dean PT; Opalenik SR; Cairo S; Judde JG; Lewis MT; Chang JC; Sanders ME; Cook RS; Skala MC; Bordeaux J; Orozco Bender J; Vaupel C; Geiss G; Hinerfeld D; Balko JM
JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32634121
[TBL] [Abstract][Full Text] [Related]
47. Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis.
Ortiz-Espinosa S; Morales X; Senent Y; Alignani D; Tavira B; Macaya I; Ruiz B; Moreno H; Remírez A; Sainz C; Rodriguez-Pena A; Oyarbide A; Ariz M; Andueza MP; Valencia K; Teijeira A; Hoehlig K; Vater A; Rolfe B; Woodruff TM; Lopez-Picazo JM; Vicent S; Kochan G; Escors D; Gil-Bazo I; Perez-Gracia JL; Montuenga LM; Lambris JD; Ortiz de Solorzano C; Lecanda F; Ajona D; Pio R
Cancer Lett; 2022 Mar; 529():70-84. PubMed ID: 34971753
[TBL] [Abstract][Full Text] [Related]
48. Effects of Shugan Jianpi Formula () on myeloid-derived suppression cells-mediated depression breast cancer mice.
Lu YT; Li J; Qi X; Pei YX; Shi WG; Lin HS
Chin J Integr Med; 2017 Jun; 23(6):453-460. PubMed ID: 27796822
[TBL] [Abstract][Full Text] [Related]
49. Chinese herbal medicine Baoyuan Jiedu decoction inhibits the accumulation of myeloid derived suppressor cells in pre-metastatic niche of lung via TGF-β/CCL9 pathway.
Tian S; Song X; Wang Y; Wang X; Mou Y; Chen Q; Zhao H; Ma K; Wu Z; Yu H; Han X; Wang H; Wang S; Ji X; Zhang Y
Biomed Pharmacother; 2020 Sep; 129():110380. PubMed ID: 32554250
[TBL] [Abstract][Full Text] [Related]
50. Angiotensin II promotes primary tumor growth and metastasis formation of murine TNBC 4T1 cells through the fibroblasts around cancer cells.
Takiguchi T; Takahashi-Yanaga F; Ishikane S; Tetsuo F; Hosoda H; Arioka M; Kitazono T; Sasaguri T
Eur J Pharmacol; 2021 Oct; 909():174415. PubMed ID: 34375673
[TBL] [Abstract][Full Text] [Related]
51. Cargo-free immunomodulatory nanoparticles combined with anti-PD-1 antibody for treating metastatic breast cancer.
Zhang Y; Hughes KR; Raghani RM; Ma J; Orbach S; Jeruss JS; Shea LD
Biomaterials; 2021 Feb; 269():120666. PubMed ID: 33461057
[TBL] [Abstract][Full Text] [Related]
52. Donor myeloid derived suppressor cells (MDSCs) prolong allogeneic cardiac graft survival through programming of recipient myeloid cells in vivo.
Cai S; Choi JY; Borges TJ; Zhang H; Miao J; Ichimura T; Li X; Xu S; Chu P; Eskandari SK; Allos H; Alhaddad JB; Muhsin SA; Yatim K; Riella LV; Sage PT; Chandraker AK; Azzi JR
Sci Rep; 2020 Aug; 10(1):14249. PubMed ID: 32859934
[TBL] [Abstract][Full Text] [Related]
53. Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis.
Safarzadeh E; Orangi M; Mohammadi H; Babaie F; Baradaran B
J Cell Physiol; 2018 Apr; 233(4):3024-3036. PubMed ID: 28661031
[TBL] [Abstract][Full Text] [Related]
54. Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies.
Shou D; Wen L; Song Z; Yin J; Sun Q; Gong W
Oncotarget; 2016 Sep; 7(39):64505-64511. PubMed ID: 27542274
[TBL] [Abstract][Full Text] [Related]
55. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
[TBL] [Abstract][Full Text] [Related]
56. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.
Holtzhausen A; Harris W; Ubil E; Hunter DM; Zhao J; Zhang Y; Zhang D; Liu Q; Wang X; Graham DK; Frye SV; Earp HS
Cancer Immunol Res; 2019 Oct; 7(10):1672-1686. PubMed ID: 31451482
[TBL] [Abstract][Full Text] [Related]
57. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Takai K; Le A; Weaver VM; Werb Z
Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
[TBL] [Abstract][Full Text] [Related]
58. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.
De Cicco P; Ercolano G; Ianaro A
Front Immunol; 2020; 11():1680. PubMed ID: 32849585
[TBL] [Abstract][Full Text] [Related]
59. Myeloid-derived suppressor cells in breast cancer.
Markowitz J; Wesolowski R; Papenfuss T; Brooks TR; Carson WE
Breast Cancer Res Treat; 2013 Jul; 140(1):13-21. PubMed ID: 23828498
[TBL] [Abstract][Full Text] [Related]
60. Myeloid-derived suppressor cells: The green light for myeloma immune escape.
Malek E; de Lima M; Letterio JJ; Kim BG; Finke JH; Driscoll JJ; Giralt SA
Blood Rev; 2016 Sep; 30(5):341-8. PubMed ID: 27132116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
